《半日總結》恆指跌387點 匯控下滑逾4% 中電信彈高
港股今日早市隨外圍股市向下,匯控(00005.HK)及友邦(01299.HK)拖低大市。恆指今早低開299點後跌幅擴大,最多跌435點一度低見28,365;其後跌幅一度收窄,惟中午跌幅再度擴大。恆指半日跌387點或1.35%,報28,413點;國指跌112點或1%,報10,533點;恆生科技指數半日跌124點或1.6%,報7,916點。大市半日成交總額885.64億元。滬、深港通南下交易半日錄得淨流入金額分別爲2.12億及28.29億元人民幣。
匯控(00005.HK)簽訂諒解備忘,潛在出售法國零售銀行業務,半日股價跌4.2%報45.15元,摩根士丹利指匯控擬售法零售銀行料致稅前虧損23億美元略高市場預期。友邦(01299.HK)跌2.8%。
中電信(00728.HK)指今年派息比率不低於60%,且明年起派中期息,股價逆市揚8.6%收2.53元。中移動(00941.HK)、聯通(00762.HK)分別升3%、1.5%。
新經濟股偏弱,京東(09618.HK)、騰訊(00700.HK)、美團(03690.HK)、阿裏巴巴(09988.HK)分別跌3%、2.2%、1.5%及0.9%。手機股小米(01810.HK)跌3%。瑞聲(02018.HK)、舜宇(02382.HK)分別升2.8%、0.4%。
工行(01398.HK)、建行(00939.HK)均跌0.8%。汽車股造好,吉利(00175.HK)、比亞迪(01211.HK)分別升4.6%、0.9%。長汽(02333.HK)彈6.4%。鞍鋼(00347.HK)預報上半年純利按年增8.6倍,早市股價逆市揚4.8%。
生物科技股強勢,藥明生物(02269.HK)再創新高,股價半日升4.5%報138元。,康龍化成(03759.HK)和方達控股(01521.HK)分別升3.7%及1.3%。
本週三將公佈全年度業績的波司登(03998.HK)早市股價再升6.6%,曾高見4.97元再創上市新高。
錦欣生殖(01951.HK)獲瑞信上調目標價,早市股價漲10.9%。電子煙概念股思摩爾(06969.HK)挫9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.